Understanding the absolute and relative risk of human immunodeficiency virus type 1 (HIV) acquisition during pregnancy and the postpartum period can inform HIV prevention strategies for women.
People infected and affected by HIV face multiple, far-reaching barriers every day – from structural barriers affecting their access to services and care, to societal and scientific barriers keeping them from enjoying healthy, safe, and full lives. We highlight some of these barriers, and what innovative approaches are being developed to bridge them.
One of the most powerful plenaries during AIDS 2018 took place on the final morning, under the theme Building bridges for the next generation, featuring MTV Shuga, a behavior change and demand creation campaign which seeks to impact young people and fight HIV.
Data helps provide insight into what is working and what needs to be changed to improve outcomes along the HIV cascade of care. The Tingathe Outreach Program uses monitoring & evaluation and research data to provide the highest quality services and most cost-effective strategies to support patients and providers along the HIV cascade. At AIDS 2018, Tingathe presented on how they use data to inform the program.
People who started HIV treatment in Swaziland under a universal test and treat policy were seven times more likely to still be in care and to have a fully suppressed viral load six months after starting treatment when compared to management of patients under the existing standard of care, Velephi
Two large studies of community-based universal test and treat campaigns to promote HIV diagnosis, treatment and prevention, presented at the 22nd International AIDS Conference (AIDS 2018) in Amsterdam on Wednesday, show that the campaigns achieved ver
The International AIDS Society (IAS) has presented its prestigious prizes and awards for innovation in HIV research, leadership in protecting human rights and the most promising work by an emerging generation of early-career scientists at the 22nd International AIDS Conference (AIDS 2018).
In the early stages of oral pre-exposure prophylaxis (PrEP) implementation, two key elements to a successful program have emerged: implementation science to inform rollout and demand creation strategies to promote the product. The pre-conference session ‘Insight to Impact: Driving Demand Creation for HIV Prevention’, organized by the OPTIONS Consortium explored the intersections of public health science and marketing and communications to understand how to drive demand for HIV prevention.